10x Genomics (TXG) Debt Ratio (2018 - 2019)
10x Genomics' (TXG) quarterly Debt Ratio came in at 0.05 in Q4 2019, down 79.45% year-over-year from 0.24 in Q4 2018, and down 5.37% quarter-over-quarter from 0.05 in Q3 2019.
Powered by 
Analysis
10x Genomics (TXG) Debt Ratio (2018 - 2019) Analysis & Trends
10x Genomics has disclosed Debt Ratio across 2 years of filings, most recently posting 0.05 for Q4 2019.
- In Q4 2019, Debt Ratio fell 79.45% year-over-year to 0.05; the TTM figure through Dec 2019 stood at 0.05 (down 79.45% YoY), while the FY2019 annual figure was 0.05, down 79.45% from the prior year.
- Debt Ratio came in at 0.05 for Q4 2019 at 10x Genomics, down from 0.05 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.24 in Q4 2018 to a low of 0.05 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 0.40 |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 0.30 |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 0.30 |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 0.30 |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 0.27 |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 0.08 |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 0.16 |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 0.19 |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 0.30 |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 0.05 |
| Sep 30, 2019 | 0.05 |
| Dec 31, 2018 | 0.24 |